Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CYTRX CORP | 350,000 | reported | 11 Jan 2016 | tx 1+350,000 |
| Contineum Therapeutics, Inc. | 14,750 | reported | 26 Jun 2025 | tx 2+18,450 |
| Arcellx, Inc. | 0 | reported | 28 Apr 2026 | tx 17+102,254−102,254 |
| Revance Therapeutics, Inc. | 0 | reported | 06 Feb 2025 | tx 13+95,576−31,675 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 36,806 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 11,459 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 8,011 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 9,174 | — | deriv |
| 26 Jun 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 14,750 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Arcellx, Inc. | 9,174 | 0.00 USD | deriv |
| 04 Feb 2025 | TENDER | Revance Therapeutics, Inc. | 16,675 | 3.65 USD | |
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 15,000 | — | |
| 28 May 2024 | GRANT_AWARD | Arcellx, Inc. | 8,011 | 0.00 USD | deriv |
| 24 May 2024 | GRANT_AWARD | Contineum Therapeutics, Inc. | 3,700 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 15,000 | 0.00 USD | |
| 01 May 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 23,458 | 0.00 USD | deriv |
| 16 Apr 2024 | EXERCISE | Arcellx, Inc. | 9,402 | 7.61 USD | |
| 16 Apr 2024 | SALE | Arcellx, Inc. | 2,612 | 56.03 USD | |
| 16 Apr 2024 | SALE | Arcellx, Inc. | 6,790 | 55.36 USD | |
| 16 Apr 2024 | EXERCISE | Arcellx, Inc. | 9,402 | 0.00 USD | deriv |
| 15 Mar 2024 | SALE | Arcellx, Inc. | 3,337 | 70.99 USD | |
| 15 Mar 2024 | SALE | Arcellx, Inc. | 3,763 | 70.36 USD | |
| 15 Mar 2024 | SALE | Arcellx, Inc. | 1,900 | 69.44 USD | |
| 15 Mar 2024 | EXERCISE | Arcellx, Inc. | 9,000 | 7.61 USD | |
| 15 Mar 2024 | EXERCISE | Arcellx, Inc. | 9,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Arcellx, Inc. | 11,459 | 0.00 USD | deriv |
| 03 May 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 3,534 | 0.00 USD | |
| 03 May 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 5,915 | 0.00 USD | deriv |
| 16 May 2022 | GRANT_AWARD | Arcellx, Inc. | 55,208 | 0.00 USD | deriv |